Shares of Zydus Lifesciences slipped 2.97% to Rs 989 on Friday at 11:58 am, ranking among the top losers on the Nifty Next 50 index amid heavy trading volumes. Despite the stock’s dip, the company reported robust financial growth. For Q1 FY26 (June 2025), revenue stood at Rs 6,573.70 crore, up from Rs 6,207.50 crore in June 2024, while net profit rose to Rs 1,486.60 crore from Rs 1,463.60 crore a year ago. EPS also improved to 14.58. On an annual basis, Zydus reported FY25 revenue of Rs 23,241.50 crore and net profit of Rs 4,614.80 crore, compared to Rs 19,547.40 crore and Rs 3,831.40 crore respectively in FY24. EPS jumped to 44.97 from 38.14. The company has announced a final dividend of Rs 11.00 per share, effective July 25, 2025. #ZydusLifesciences #StockMarket #NiftyNext50 #PharmaStocks #Earnings #Dividends

#EquityResearch#PersonalFinance#TrendingSectors#StockInNews#WatchOutFor

871 likes·34 comments